Genelux Corporation Common Stock (GNLX) stock news · rev $8.0K
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
This GNLX news page leads with what Genelux Corporation Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for GNLX yet. We will not pad this page with generic market recap.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GNLX stock page; for the tape open the quote page.
GNLX stock news FAQ
What are GNLX's latest revenue and net income?
Latest cached Genelux Corporation Common Stock (GNLX) revenue for Dec 31, 2025 was $8.0K. Net income was -$32.1M. Statements: https://lician.com/financials/gnlx
How did GNLX revenue change from the prior cached period?
Cached Genelux Corporation Common Stock (GNLX) revenue was unchanged from $8.0K (Dec 31, 2024) to $8.0K (Dec 31, 2025). Statements: https://lician.com/financials/gnlx
What is GNLX's market cap?
Genelux Corporation Common Stock (GNLX) market cap is $130.6M on the latest cached fundamentals snapshot.
What kind of company is GNLX?
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Where is GNLX stock news listed?
Cached stock news for Genelux Corporation Common Stock (GNLX) is listed at https://lician.com/news/gnlx. Filings: https://lician.com/sec/gnlx
Not investment advice.